Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hydroxypropyl cellulose is a semi-synthetic derivative of cellulose used primarily as an ophthalmic lubricant and protectant. It acts as an artificial tear to relieve dryness and irritation caused by reduced tear flow in conditions such as keratoconjunctivitis sicca (dry eye syndrome) and recurrent corneal erosions. The drug works by stabilizing and thickening the precorneal tear film, prolonging its breakup time, lubricating the ocular surface, and protecting against further irritation or injury. Hydroxypropyl cellulose is also widely used in the pharmaceutical industry as an excipient—serving roles such as tablet binder, thickener, coating agent, and film former—and in food products as a thickener or emulsion stabilizer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hydroxypropyl cellulose.